Philip Showalter Hench, an American clinical pathologist, performed groundbreaking research in rheumatoid arthritis . His clinical tests of adrenal compound E, which Hench named cortisone, and of ACTH , which produces cortisone naturally by stimulating...

Philip Showalter Hench, an American clinical pathologist, performed groundbreaking research in rheumatoid arthritis. His clinical tests of adrenal compound E, which Hench named cortisone, and of ACTH, which produces cortisone naturally by stimulating...

Philip Hench made important advances in the understanding and hormonal treatment of arthritis and other rheumatic diseases. For his accomplishments, he received part of the 1950 Nobel prize for physiology or medicine, which he shared with his co-worker...

1896-1965 American physician who is known for his contribution in the treatment of rheumatism, an umbrella term that includes arthritis and other pains associated with the joints and muscles. His research with arthritis led him to discover that in some...

Philip Showalter Hench (February 28, 1896 – March 30, 1965) was an American physician who, with E. C. Kendall, in 1948 successfully applied an adrenal hormone (later known as cortisone) in the treatment of rheumatoid arthritis at the Mayo Clinic....

In 1950, Philip Showalter Hench shared the Nobel Prize in physiology or medicine with his colleague Edward Calvin Kendall (1886-1972) and Polish-Swiss chemist Tadeus Reichstein (1897-1996) for their "discoveries relating to the hormones of the adrenal cortex, their structure, and biological effects." Their work...

Caesar-Verona, Inc. a Seattle, WA investment group, has announced that it has purchased Hench Control Corp. of San Jose, CA, to be operated as a wholly-owned subsidiary. Alex Daneman, President of Caesar-Verona was named as the CEO of Hench Control as of March...